Through this mechanism, the drug increases insulin release from the pancreas, while also reducing glucose production in the liver and slowing down stomach emptying
Re: Wegovy: FDA approves weight loss drug to cut cardiovascular risk
Another general advice is to begin with a lower dose and gradually increase it to detect any side effects
It's important to acknowledge that these are common, with studies indicating that a significant percentage of users (reports range from 40% up to 85%) experience issues like nausea, vomiting, diarrhea, constipation, bloating, or heartburn, particularly when first starting the medication or increasing the dose
C.da SilvaL
This weight regain is not due to medication "dependence" in the traditional sense, but rather reflects the underlying biology of obesity as a chronic condition